hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor for immunotherapy of uterine serous papillary carcinoma

Overview of attention for article published in British Journal of Cancer, August 2010

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

patent: 12 patents

Readers on

mendeley: 22 Mendeley

So far, Altmetric has seen 12 patents that reference this research output.

Tissue factor-targeting CAR-NK and CAR-T cell therapy

Grant US-12630605-B2

United States of America

19 May 2026

Fusion immunomodulatory proteins and methods for making same

Grant US-12351636-B2

United States of America

08 Jul 2025

Anti-EGFR1-PD1 targeted/immunomodulatory fusion protein

Grant US-12049632-B2

United States of America

30 Jul 2024

Methods and compositions related to a tissue factor-targeting IGG3 immunoconjugates

Grant US-11872194-B2

United States of America

16 Jan 2024

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 8 additional patents.